You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

apalutamide

Showing 51 - 62 of 62
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Oligometastatic Prostate Carcinoma Trial in Houston

Withdrawn
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Apalutamide
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2021

Prostatic Tumors Trial in Worldwide (Radiotherapy, LHRHa, Apalutamide)

Recruiting
  • Prostatic Neoplasms
  • Radiotherapy
  • +2 more
  • Tucson, Arizona
  • +145 more
Jan 17, 2023

Cancer of the Prostate Trial in Singapore (Apalutamide)

Completed
  • Cancer of the Prostate
  • Apalutamide
  • Singapore, Singapore
    Department of Urology
Mar 17, 2020

Prostatic Tumors Trial in Canada, United States (Niraparib, Apalutamide, Abiraterone Acetate)

Completed
  • Prostatic Neoplasms
  • West Hollywood, California
  • +5 more
Jul 16, 2020

Prostate Cancer Trial in Houston (Apalutamide, IHT)

Withdrawn
  • Prostate Cancer
  • Houston, Texas
    UTHealth Memorial Hermann Cancer Center
Feb 25, 2020

Prostate Cancer Trial in Boston (Leuprolide Acetate, Prednisone, Docetaxel)

Terminated
Has Results
  • Prostate Cancer
  • Leuprolide Acetate
  • +3 more
  • Boston, Massachusetts
  • +1 more
Apr 2, 2020

PSA Progression, Stage III Prostate Adenocarcinoma, Stage IV Prostate Adenocarcinoma Trial in Canada, United States (drug,

Active, not recruiting
  • PSA Progression
  • +2 more
  • Apalutamide
  • +2 more
  • Gilbert, Arizona
  • +362 more
Mar 9, 2022

Prostate Cancer Trial in United States (Apalutamide, LHRH Analogue, Abiraterone Acetate)

Active, not recruiting
  • Prostate Cancer
  • Apalutamide
  • +3 more
  • Phoenix, Arizona
  • +68 more
Nov 28, 2022

Low Risk Prostate Cancer Trial in France (Apalutamide)

Unknown status
  • Low Risk Prostate Cancer
  • Apalutamide
  • Marseille, Bouches Du Rhône, France
  • +10 more
Sep 25, 2019

Prostatic Tumors Trial in Japan (Androgen-deprivation Therapy (ADT), Bicalutamide, Abiraterone)

Active, not recruiting
  • Prostatic Neoplasms
  • Androgen-deprivation Therapy (ADT)
  • +6 more
  • Akita, Japan
  • +76 more
Jan 19, 2023

Prostate Cancer Trial in Cambridge (Apalutamide)

Completed
  • Prostate Cancer
  • Apalutamide
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust/Addenbrookes
Nov 18, 2019

Prostatic Tumors, Castration-Resistant Trial in New York (JNJ-809, Apalutamide)

Withdrawn
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    (unnamed)
Nov 18, 2016